Discover how market concentration, AI dominance, and Capital One's transformative acquisition are reshaping portfolios. Read ...
16h
Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the second cohort of its Cell & Gene Therapy Incubator Program (CIP). Launched in December 2024, with the inaugural cohort ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results